Zarkovsky A M
Pharmacol Biochem Behav. 1986 May;24(5):1215-7. doi: 10.1016/0091-3057(86)90173-5.
The metabolites of tryptophan-kynurenines with convulsant action quinolinic acid (QA) and l-kynurenine (l-KYN) antagonized the enhancing effect of pentobarbital (1 mM) on [3H]Flunitrazepam binding. IC50 for l-KYN were 35.9 +/- 14.8 microM and for QA 31.2 +/- 7.2 microM respectively. The inhibitory effect of KYN was stereoselective: IC50 of l-isomer was about two fold lower than IC50 of racemic form, d,l-KYN. Scatchard analysis revealed that inhibitory effect of QA and l-KYN on [3H]Flunitrazepam binding enhanced by pentobarbital is due to the decrease in affinity of benzodiazepine receptors. On the basis of these data it is proposed that QA and l-KYN possess their convulsant action interacting with barbiturate/picrotoxin sensitive sites of GABA-benzodiazepine-barbiturate complex.
具有惊厥作用的色氨酸-犬尿氨酸代谢产物喹啉酸(QA)和L-犬尿氨酸(L-KYN)拮抗了戊巴比妥(1 mM)对[3H]氟硝西泮结合的增强作用。L-KYN的IC50分别为35.9±14.8 microM,QA的IC50为31.2±7.2 microM。犬尿氨酸的抑制作用具有立体选择性:L-异构体的IC50比外消旋形式d,l-KYN的IC50低约两倍。Scatchard分析表明,QA和L-KYN对戊巴比妥增强的[3H]氟硝西泮结合的抑制作用是由于苯二氮䓬受体亲和力降低所致。基于这些数据,有人提出QA和L-KYN通过与GABA-苯二氮䓬-巴比妥复合物的巴比妥酸盐/印防己毒素敏感位点相互作用而具有惊厥作用。